In addition, treatment with siRNA targeting c-Rel delivered in micelles via intraperitoneal (i.p.)injection in a mouse model of imiquimod (IMQ)-induced psoriasis was shown to prevent or mitigate disease symptoms [145]. This evidence concerns the gene REL and psoriasis.